Depression is a common and chronic comorbidity in patients with interstitial lung disease.

Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA.
Respirology (Impact Factor: 3.5). 12/2011; 17(3):525-32. DOI: 10.1111/j.1440-1843.2011.02122.x
Source: PubMed

ABSTRACT Little is known about depression in interstitial lung disease (ILD). The aim of this study was to determine the prevalence of depression, characterize the association of depression with clinical variables and describe the natural history of depression in patients with ILD.
In this prospective cohort study, clinical variables were recorded at baseline and 6 months. Depression was measured with the Centre for Epidemiologic Studies Depression scale. Depression prevalence was determined using the established threshold of >15 points. Multivariate linear regression was used to determine the baseline features that independently correlated with baseline depression score and that predicted depression severity at follow-up.
Fifty-two subjects were enrolled, and 45 returned for follow-up (three deaths, one lung transplant). Prevalence of depression was 21% at baseline. Independent predictors of depressive symptoms at baseline included dyspnoea severity, pain severity, sleep quality and forced vital capacity (R(2) 0.67). The odds of clinically meaningful depression at follow-up were 34-fold higher for subjects who had clinically meaningful depression at baseline compared with those who were not (95% confidence interval 3.5-422, P < 0.0005). Baseline depression score was the strongest predictor of depression score at follow-up (r 0.59, P < 0.00005).
Depressive symptoms in ILD are common, persistent, and strongly and independently correlated with dyspnoea, pain, sleep quality and forced vital capacity. Clinically meaningful depression at baseline is the most important predictor of depressive symptoms at follow-up. Patients with ILD should routinely be screened for depression.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and objectivesLittle is known about the prevalence of anxiety in interstitial lung disease (ILD), and the contributors to depression are not clear. The aim of this study was to determine the prevalence and predictors of anxiety and depression in people with ILD.Methods One hundred and twenty-four individuals with ILD (age 64 years (standard deviation 12), 48 idiopathic pulmonary fibrosis) participated. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale to determine likely cases and borderline cases. Associations with demographic data, respiratory function, 6-min walk and Modified Medical Research Council Dyspnoea Scale (MMRC) were examined.ResultsThe prevalence of anxiety was 31%, with clinically significant anxiety in 12%. Depression was present in 23% of individuals, with 7% having clinically significant depression. Independent predictors of anxiety were a higher MMRC score (P = 0.005, odds ratio (OR) for case 2.60, 95% confidence interval 1.37 to 4.92) and higher nadir SpO2 during walking (P = 0.003, OR for case 1.16, 1.04–1.30). Independent predictors of depression were a higher MMRC score (P = 0.006, case OR 3.84, 1.25–11.78, borderline case OR 2.44, 1.14–5.19) and a greater number of comorbidities (P = 0.003, case OR 2.02, 0.97–4.21, borderline case OR 2.26, 1.30–3.93).Conclusions Anxiety and depression are present in a significant minority of individuals with ILD. Dyspnoea and comorbidities are important contributors that may be amenable to intervention.
    Respirology 09/2014; 19(8). DOI:10.1111/resp.12360 · 3.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pain in patients awaiting lung transplantation is not well known.
    Journal of Pain and Symptom Management 08/2014; DOI:10.1016/j.jpainsymman.2014.07.011 · 2.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The world's population is ageing and an important part of this demographic shift is the development of chronic illness. In short, a person who does not die of acute illnesses, such as infections, and survives with chronic illnesses is more likely to develop additional chronic illnesses. Chronic respiratory diseases are an important component of these diseases associated with ageing. This article reviews the relationship between ageing and chronic respiratory disease, and also how certain chronic diseases cluster with others, either on the basis of underlying risk factors, complication of the primary disease or other factors, such as an increased state of inflammation. While death is inevitable, disabling chronic illnesses are not. Better understanding of how individuals can age healthily without the development of multiple chronic illnesses should lead to an improved global quality of life.
    European Respiratory Journal 08/2014; 44(4). DOI:10.1183/09031936.00059814 · 7.13 Impact Factor

Full-text (2 Sources)

Available from
Oct 28, 2014